Related Experiment Video
Updated: Apr 6, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
[Updated treatment of erectile dysfunction after prostatectomy]
Erectile dysfunction (ED) affects up to 90% of men post-prostatectomy. Early penile rehabilitation with vacuum devices and PDE5 inhibitors is recommended, with other options for non-responders.
Area of Science:
- Urology
- Oncology
- Sexual Medicine
Background:
- Radical prostatectomy for prostate cancer frequently leads to erectile dysfunction (ED), impacting patient quality of life.
- Penile rehabilitation aims to restore erectile function after prostatectomy.
- Current treatments for post-prostatectomy ED include oral PDE5 inhibitors, injections, vacuum devices, and prostheses.
Purpose of the Study:
- To provide an overview of current penile rehabilitation methods for ED patients post-radical prostatectomy.
- To discuss drug treatments and device-based therapies for post-prostatectomy ED.
Main Methods:
- Review of existing literature on erectile dysfunction treatments following radical prostatectomy.
- Analysis of pharmacological and device-based rehabilitation strategies.
Main Results:
- Oral phosphodiesterase 5 inhibitors (PDE5I) are a common treatment option.
- Vacuum erection devices (VEDs) are also utilized for penile rehabilitation.
- Combination therapy with VEDs and PDE5I is suggested for early postoperative use.
Conclusions:
- Daily VED use combined with oral PDE5I is a recommended initial approach for early penile rehabilitation.
- For patients unresponsive to initial therapy, alternative treatments like intraurethral alprostadil, intracorporal injections, or penile prosthesis implantation should be considered.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Urinary Tract Calculi VI: Surgical Management

